Perforin-independent rejection of transplanted human stem cells
- PMID: 16879254
- PMCID: PMC1809682
- DOI: 10.1111/j.1365-2249.2006.03128.x
Perforin-independent rejection of transplanted human stem cells
Abstract
The NOD/SCID mouse model is one of the most established model systems for the analysis of human stem cells in vivo. The lack of mature B and T cells renders NOD/SCID mice susceptible to transplantable human stem and progenitor cells. One remaining functional component of the immune system in NOD/SCID mice is natural killer (NK) cells. We rationalized that by eliminating NK cell-mediated cytotoxicity in this model system engraftment of human haematopoietic stem cells could be improved. Thus perforin-deficient NOD/SCID mice (PNOD/SCID) were generated, which display a complete lack of NK cell-mediated cytotoxicity. To test the engraftment potential of human stem cells in PNOD/SCID mice, we compared the repopulating potential of human haematopoietic stem cells in these mice with the repopulating potential in NOD/SCID mice. Upon injection with varying numbers of mononuclear cells from human cord blood, the number of engrafted PNOD/SCID mice was lower (34.8%) than the number of engrafted NOD/SCID mice (64.7%). Similarly, injection of purified CD34(+) human cord blood cells led to engraftment in 32.3% PNOD/SCID versus 60% in NOD/SCID mice. Surprisingly, these results show that the inactivation of cytotoxic activity of NK cells in PNOD/SCID mice did not result in better engraftment with human haematopoietic stem cells. A potential reason for this observation could be that compensatory activation of NK cells in PNOD/SCID mice induces high levels of soluble factors resulting in an environment unfavourable for human stem cell engraftment.
Figures



Similar articles
-
Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.Bone Marrow Transplant. 2000 Dec;26(11):1211-6. doi: 10.1038/sj.bmt.1702702. Bone Marrow Transplant. 2000. PMID: 11149733
-
NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment.Transplantation. 2003 Oct 15;76(7):1036-42. doi: 10.1097/01.TP.0000083041.44829.2C. Transplantation. 2003. PMID: 14557749
-
Intrahepatic transplantation of CD34+ cord blood stem cells into newborn and adult NOD/SCID mice induce differential organ engraftment.Tissue Cell. 2012 Apr;44(2):80-6. doi: 10.1016/j.tice.2011.11.004. Epub 2011 Dec 23. Tissue Cell. 2012. PMID: 22197619
-
SCID mouse models of human stem cell engraftment.Stem Cells. 1998;16(3):166-77. doi: 10.1002/stem.160166. Stem Cells. 1998. PMID: 9617892 Review.
-
[The immuno-deficient mice transplantion models in study of human hematopoietic stem cells--review].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Dec;12(6):875-9. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004. PMID: 15631683 Review. Chinese.
Cited by
-
Establishing humanized mice using stem cells: maximizing the potential.Clin Exp Immunol. 2008 Jun;152(3):406-14. doi: 10.1111/j.1365-2249.2008.03659.x. Epub 2008 Apr 24. Clin Exp Immunol. 2008. PMID: 18435804 Free PMC article. Review.
References
-
- Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature. 1983;301:527–30. - PubMed
-
- Imada K. Immunodeficient mouse models of lymphoid tumors. Int J Hematol. 2003;77:336–41. - PubMed
-
- Bosma MJ, Carroll AM. The SCID mouse mutant: definition, characterisation, and potential uses. Annu Rev Immunol. 1991;9:323–50. - PubMed
-
- Greiner DL, Hesselton RA, Shultz LD. SCID mouse models of human stem cell engraftment. Stem Cells. 1998;16:166–77. - PubMed
-
- Lieber MR, Hesse JE, Lewis S, et al. The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination. Cell. 1988;55:7–16. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources